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Presurgical evaluationIntracranial EEG (icEEG)monitoring is critical in epilepsy surgical planning, but it has limitations. The advances of
neuroimaging have made it possible to reveal epileptic abnormalities that could not be identiﬁed previously and
improve the localization of the seizure focus and the vital cortex. A frequently asked question in the ﬁeld is
whether non-invasive neuroimaging could replace invasive icEEG or reduce the need for icEEG in presurgical
evaluation. This review considers promising neuroimaging techniques in epilepsy presurgical assessment in
order to address this question. In addition, due to large variations in the accuracies of neuroimaging across
epilepsy centers, multicenter neuroimaging studies are reviewed, and there is much need for randomized con-
trolled trials (RCTs) to better reveal the utility of presurgical neuroimaging. The results of multiple studies indi-
cate that non-invasive neuroimaging could not replace invasive icEEG in surgical planning especially in non-
lesional or extratemporal lobe epilepsies, but it could reduce the need for icEEG in certain cases. With technical
advances, multimodal neuroimaging may play a greater role in presurgical evaluation to reduce the costs and
risks of epilepsy surgery, and provide surgical options for more patients with drug-resistant epilepsy.
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Epilepsy affects approximately 50 million people worldwide (WHO,
2009). Around 30% of those with partial seizures are resistant to antiep-
ileptic drugs and may need surgical treatment (Arroyo, 2000; Guerrini
et al., 2003). Epilepsy surgery is aimed at removing the epileptogenic
zone (seizure focus) as complete as possible while avoiding neurologi-
cal deﬁcits (Seeck et al., 2010), and surgical results in seizure control
have reached 60% to 90% seizure-free outcome in patients with tempo-
ral lobe epilepsy (TLE) and 40% to 60% in extratemporal lobe epilepsy
(ETLE) (Tellez-Zenteno et al., 2005).
Precise localization of the epileptogenic focus is a prerequisite for
seizure-free outcome, but it remains a challenge, especially for non-
lesional epilepsy (usually with negative or normal MRI) and ETLE. In
TLE, around 30% of patients with intractable TLE have normal (or nega-
tive) MRI (Hammen and Kuzniecky, 2012). Patients with MRI-positive
(i.e., a visible MRI lesion) TLE have good surgical outcomes (60–90%
chance of seizure freedom), while patients with MRI-negative TLE
have less favorable outcomes (40%–70%) (Brodbeck et al., 2010), and
patients with MRI-negative ETLE have the worst outcome (40%–60%)
(Tellez-Zenteno et al., 2010).
The main tasks in presurgical evaluation are to delineate the epilep-
togenic zone and localize the vital eloquent cortex, but the presurgical
evaluation of patients with medically refractory epilepsy is often
lengthy and expensive, and even non-localizing in a signiﬁcant percent-
age of patients (Berg et al., 2003; Spencer, 1998; Thivard et al., 2006). At
present, presurgical localization of the epileptogenic zone and function-
al cortex in non-lesional and extratemporal lobe epilepsies still relies
largely on invasive intracranial electrodes. Comparedwith scalp EEG, in-
tracranial electroencephalogram (icEEG) has high sensitivity and space
speciﬁcity (Blount et al., 2008; Vulliemoz et al., 2011) and is the “gold
standard” for delineating the epileptogenic zone (Blount et al., 2008).
However, it is invasive, sample-limited, costly and risky with potential
complications such as (subdural, epidural or intra-cerebral hematomas)
bleeding and infections (Blount et al., 2008; Seeck et al, 2010).
Structural neuroimaging such as MRI and functional neuroimaging
such as PET (Positron Emission Tomography) and SPECT (Single Photon
Emission Computed Tomography) have become an essential part of
presurgical evaluation in selecting patients and planning icEEG record-
ings (Whiting et al., 2006;Widjaja and Raybaud, 2008). Recent advances
in neuroimaging such as MRI morphometry, DTI (Diffusion Tensor
Imaging), MRS (Magnetic Resonance Spectroscopy)/MRSI (MRS
Imaging), EEG–fMRI, EEG/ESI (Electronic Source Imaging) and MEG
(Magnetoencephalography)/MSI (Magnetic Source Imaging) have
improved patient selection and surgical decision making (Whiting
et al., 2006).
However, can non-invasive neuroimaging replace invasive icEEG or
reduce the need for icEEG in presurgical evaluation? This paper consid-
ered promising neuroimaging techniques in localizing the epileptogenic
zone and the eloquent cortex, and reviewedmulticenter studies that used
neuroimaging techniques in presurgical evaluation. The paper was orga-
nized in four sections, and each section addressed one frequently-asked
question in the ﬁeld.
2. Can non-invasive neuroimaging techniques replace or reduce the
need for invasive icEEG monitoring in focus localization?
2.1. Summary of previous ﬁndings
A comprehensive review by Whiting et al. found that ictal SPECT
had the highest sensitivity (70–100%) and speciﬁcity (93–100%) in
TLE and was most promising than other tests (interictal SPECT, PET,
etc.) (Whiting et al., 2006). Earlier studies comparing MRI, SPECT and
PET also showed that the highest diagnostic accuracy was achieved by
ictal SPECT (90% in TLE and 81% in ETLE), followed by 84% for interictal
PET vs. 71% for quantitative MR imaging and 66% for interictal SPECT(Spencer, 1994; Spencer et al., 1995). It has been reported that the
overall sensitivity and speciﬁcity of interictal FDG-PET (Fig. 2B) and
ictal SPECT are similar in large series of partial epilepsies (Engel et al.,
2008). In addition, volumetric MRI and PET appear promising, while
MRS (Magnetic Resonance Spectroscopy) and SISCOM (subtraction
ictal single photon emission computed tomography co-registered to
magnetic resonance imaging) are less promising at focus localization
(Whiting et al., 2006). When MRI is normal, ictal SPECT and MRS have
much lower focus localization precision than those when MRI is abnor-
mal (ictal SPECT: 67% vs. 84%; MRS: 71% vs. 82%) in TLE (Doelken et al.,
2007). Moreover, Chandra et al. (2006) demonstrated that PET and
apparent diffusion coefﬁcient (ADC) of DTI are more accurate than
MRI and FA (Fractional Anisotropy) of DTI in identifying epileptogenic
tubers in patients with tuberous sclerosis complex (TSC). Recent
imaging techniques such as quantitative MRI, EEG–fMRI and MEG are
also found helpful in capturing subtle lesions as possible neocortical or
extratemporal foci.
2.2. Recent ﬁndings on MEG/MSI and possibility of replacing icEEG with
neuroimaging
In recent years, studies have shown that the localization accuracy of
MEG (Fig. 2C) might be closer to that of the “gold standard” icEEG
(Knowlton et al., 2006, 2008a; Lau et al., 2008; Papanicolaou et al.,
2005; Wu et al., 2006), although MEG is less available and requires
more interictal epileptiform discharges (IEDs) (Knake et al., 2006;
Knowlton et al., 1997; Pataraia et al., 2004; Stefan et al., 2003). A
study with a large sample (n = 455) showed that the sensitivity of
MEG/MSI was around 70% (72% in TLE, 67% in ETLE); while compared
with surgical site (n = 131), MEG/MSI correctly localized seizure
focus in 86% TLE and 89% ETLE cases (Stefan et al., 2003). Since MEG
covers the whole head (e.g., cortices) while icEEG is sample-limited,
MEG might be more advantageous in detecting the seizure focus than
icEEG in patientswith normalMRI. Papanicolaou et al. (2005) compared
the localization accuracy of interictal MEGwith ictal and interictal inva-
sive video-EEG in identifying the epileptogenic zone in 41 epilepsy sur-
gery candidates (29 TLE, 12 ETLE) and found that the overall localization
accuracy was 54% of icEEG vs. 56% of MEG (in TLE, icEEG 55.2% vs. MEG
65.5%; in ETLE, icEEG 50.0% vs. MEG 33.3%). Thus, the authors concluded
that MEG was statistically equivalent accurate to icEEG. Knowlton et al.
prospectively evaluated the results of MSI and icEEG in 49 patients with
partial epilepsy (most had normal or non-localizing MRI). They found
that MEG/MSI could correctly localize the epileptogenic source at
sublobar level in 65.3% (32/49) patients and icEEG in 69.4% (34/49),
and the ratios of MEG vs. icEEG were nearly the same in TLE and
ETLE (Knowlton et al., 2006). However, spikes were localized by icEEG
(not by MEG) in 14.3% of the cases, and vice versa in 6.1% of the cases
(Knowlton et al., 2006), indicating that icEEG could not be replaced in
these cases.
The Ontario Health Technology Advisory Committee (OHTAC)
reported that there was some “limited observational data (ﬁve studies,
n = 190) to suggest that MEG may be as accurate as invasive EEG at
localizing the seizure foci.” and called for a ﬁeld evaluation to determine
the potential substitutive role of MEG vs. icEEG (OHTAC, 2007).
Knowlton et al. investigated presurgical neuroimaging (including 148-
channel MEG/MSI, 18FDG-PET and ictal SPECT) in comparison to
icEEG (Knowlton et al., 2008a,b). They examined 77 patients with
normal MRI or ambiguous MRI abnormalities (39 TLE, 33 ETLE, 5 non-
localized), and found that icEEG localized the seizure focus in 54
(70.1%) cases while MEG/MSI in 47 (61%) cases; icEEG indicated non-
localized seizure onsets in 18 cases while MEG/MSI in 14; and icEEG
did not capture seizures in 5 (6.5%) cases while MEG/MSI in 16
(20.8%) (Knowlton et al., 2008a). The results indicated that MEG/MSI
could not replace icEEG in focus localization.
When MRI and/or ictal scalp EEG is not localizing, MEG/MSI can
detect medial temporal spikes and it may provide important localizing
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2010). Using 151-channel MEG, Agirre-Arrizubieta et al. (2009) found
that 56% of all interictal icEEG spikes had an interictal MEG counterpart,
the association between the two varied (≥90% in the interhemispheric
and frontal orbital region; ~75% in the superior frontal, central and
lateral temporal regions; ~25% in the mesial temporal region), and a
large number of interictal icEEG spikes were not detected by MEG
indicating thatMEG cannot substitute for icEEG in localization of seizure
onsets (Wennberg, 2006). Further, Knowlton et al. (2008a) demonstrat-
ed that MEG/MSI, PET and ictal SPECT alone or in combination could
not replace icEEG. These ﬁndings showed that current neuroimaging,
either single modality or combined multimodalities, could not be an
alternative to icEEG in presurgical focus localization, especially in
difﬁcult epilepsy cases such as non-lesional or bilateral TLE or ETLE.
2.3. Limitations of icEEG as a “gold standard”
Nevertheless, the limitations of the icEEG as a “gold standard” in
focus localization cannot be ignored. Even with widespread cortical
coverage, sampling errors (due to limited-sampling) may occur
(Duchowny, 2009) and sometimes, the electrodes have to be removed
with non-localizing results (Wetjen et al., 2009). Because of such limita-
tions, the diagnostic values of neuroimaging tests are lower than “true
values” (Knowlton et al., 2008a). Knowlton reported that seven patients
had non-localizing icEEG ﬁndings, underwent surgery anyway (based
on neuroimaging ﬁndings), and became seizure-free (Knowlton et al.,
2008a). Such false-negative icEEG cases demonstrated that icEEG may
potentially be skipped in these cases, while neuroimaging ﬁndings
could lead to correct surgical decisions and good surgical outcomes.
Further, the time required for presurgical icEEG monitoring is long
(from several days to several weeks depending on the need of seizure
monitoring), while the time for neuroimaging is relatively short
(from several minutes to several hours (e.g., MRI or PET/MEG)) which
is advantageous.
2.4. Multimodal neuroimaging
On the other hand, itwas found thatMEG spatio-temporal analysis is
more adequate inmodeling frontotemporal spikes on icEEG than that of
EEG (Tanaka et al., 2010), MEG/MSI has higher diagnostic accuracy than
PET or ictal SPECT and diagnostic gainmay be achieved by adding either
PET or ictal SPECT to MEG/MSI (Knowlton et al., 2008a). There is an
evolving consensus that the combined use of these imaging techniques
improves the accuracy of focus localization (Barkley and Baumgartner,
2003; Fuchs et al., 1998; Knowlton et al., 2008a,b; Madan and Grant,
2009). In other words, a multimodal imaging approach could use con-
cordant imaging ﬁndings to achieve better focus localization (Knake
et al., 2006;Moeller et al., 2009; Stefan et al., 2003; Zijlmans et al., 2007).
If the ﬁndings of two modalities (e.g., MRI and EEG/ESI) are concor-
dant or complementary, then the localization conﬁdence is increased,
but if they are discordant, another imaging modality (e.g., PET) or
icEEG is needed. The concordance between quantitative MRI, PET and
MRS is around 73% (Kuzniecky et al., 1998; Park et al, 2001) and the
concordance between pathological diagnosis and MRI, PET, ictal SPECT
and icEEG varies from55% to 85% (Wonet al., 1999). In addition, concor-
dance rates of interictal PET and ictal SPECT for temporal lesions are 96%
and 100% respectively and respective rates for extratemporal lesions
were 68% and 92% (Kim et al., 2009). Moreover, MRS (Fig. 2A) markers
such as unilateral decrease of NAA/Cr, NAA/Cho, or NAA/Cr + Cho
ratios demonstrated good concordance with localization of the epilep-
togenic zone identiﬁed by EEG, MRI, and FDG-PET (Cendes et al.,
1997a, 1997b; Guye et al., 2002; Hajek et al., 2009; Hammen et al.,
2006; Kantarci et al., 2002; Maton et al., 2001; Meyer et al., 2001; Park
et al., 2001; Someya et al., 2000). Since concordant imaging ﬁndings
could achieve better focus localization, usingmultimodal neuroimaging
might lead to fewer patients undergoing invasive icEEG (Health Net,2010). Further, it was found that MEG/MSI, PET and ictal SPECT each
have clinical value in predicting surgical outcome for patients with
non-localized MRI or video-EEG, and MEG/MSI was close to ictal icEEG
in predicting a good surgical outcome (Knowlton et al., 2008b).
2.5. Possibility of reducing the need for icEEG
Although neuroimaging could not replace icEEG in focus localization,
a number of studies have reported that non-invasive neuroimaging
tests could reduce the need for icEEG monitoring (Knowlton et al.,
2006, 2008a,b; Papanicolaou et al., 2005; Thomas et al., 2002). In mesial
temporal lobe epilepsy (MTLE), precise localization of the epileptogenic
focus to a very small brain regionwith icEEG is not necessary (Tran et al.,
1995; Zumsteg et al., 2006). Similarly, in epilepsies of clear structural
abnormalities (such as hippocampal sclerosis or atrophy) detected by
(high-resolution) MRI, plus concordant symptomatology of partial
seizures and good lateralization of scalp EEG, icEEG is not necessary
(Blount et al., 2008). However, the situations where invasive icEEG
can be skipped are yet to be identiﬁed.
Recent advances in neuroimaging improve clinical yields and make
it possible to capture formerly “non-lesional” subtle lesions and localize
seizure focus in extratemporal lobe regions with improved accuracy.
Structural neuroimaging such as high-resolution MRI, MRI morphome-
try, voxel-based intensity analysis and DTI increasingly revealed
previously undetected “non-lesional” dysplastic lesions (Bernasconi
et al., 2011; Chen et al., 2008; Guye et al., 2007; Rugg-Gunn et al.,
2001; Thivard et al., 2006). For example,MRI voxel-basedmorphometry
(VBM) analysis could detect focal cortical dysplasia (FCD) with high
accuracy (sensitivity: 63–95%, speciﬁcity: 91–100%) (Bruggemann
et al., 2007; Colliot et al., 2006a), while DTI (Fig. 2D) could capture
“non-lesional” diffusion abnormalities (Guye et al., 2007; Thivard
et al., 2006). These techniques have provided surgical options for
more patients with drug-resistant epilepsy (Bernasconi et al., 2011).
In functional neuroimaging, ictal SISCOM is found more reliable on the
diagnosis of the epileptogenic focus than ictal SPECT, it has high concor-
dance (92.5%) with the surgical site (n = 123) (Matsuda et al., 2009)
and has remarkable predictive value for surgical outcome (La Fougère
et al., 2009). In addition, the clinical yield of 128-channel EEG/ESI
(EEG Source Imaging) (n = 32, 17 TLE, 15 ETLE) has reached high
focus localization precision (93.7% [100% in TLE, 86.7% in ETLE] on the
lobar level; and 79% in the resected area) (Michel et al., 2004). In non-
lesional (normal MRI) epilepsy, EEG/ESI could correctly localize the
epileptic focus in 80% of the patients (n = 10) (Brodbeck et al., 2010).
Comparison between EEG andMEG showed thatMEG ﬁndings correlat-
ed more with the surgical sites than those of EEG (72.3% vs. 40%)
(Pataraia et al., 2004), and in patients who had non-localizing ﬁndings
with EEG (n = 25), MEG identiﬁed the seizure focus (in the resection
lobe) in 11 (44%) of them (Paulini et al., 2007). For details on high-
density EEG/ESI in spike detection compared with MEG/MSI, see a
review by Shibasaki et al. (2007). Moreover, a number of EEG–fMRI
(Fig. 2E) validation studies compared EEG–fMRI ﬁndings with those of
icEEG (Bagshaw et al., 2004; Bénar et al., 2006; Lazeyras et al., 2000;
Moeller et al., 2009). Some showed that EEG–fMRI datawere convincing
(Groening et al., 2009; Grouiller et al., 2011; Thornton et al., 2010;
Zhang et al., 2012; Zijlmans et al., 2007) and EEG–fMRI analysis could
obtain a sensitivity comparable to PET and SPECT in focus localization
(Hauf et al., 2012). MRS (Fig. 2A) is helpful in focus lateralization in
non-lesional TLE, and NAA reduction in the affected hemisphere was
found in 66–71% of patients with unilateral TLE, indicating that 1H
MRS can provide valuable information for hemispheric lateralization
and focus localization in such patients (Hammen and Kuzniecky,
2012; Hammen et al., 2006). Further, multimodal neuroimaging is
needed not only in presurgical evaluation, but also in functional naviga-
tion in epilepsy surgery (Duncan, 2010; Kamada et al., 2003). As a result
of advances in neuroimaging, invasive icEEG is used in ~25–40% of
surgical cases in most large epilepsy centers (Faught and Blount, 2008).
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In practice, amultimodal imaging approach for presurgical evaluation
has been taken by various epilepsy centers and concordant neuroimag-
ing ﬁndings often reduce the need for icEEG in presurgical planning.
For example, in the protocol of drug-resistant epilepsy presurgical eval-
uation in Kyoto University Hospital (Fig. 1A) (Shibasaki et al., 2007), if
the ﬁndings of non-invasive techniques such as long-term video-EEG,
ESI (EEG Source Imaging), MRI, FDG-PET, ictal SPECT and/or MEG are
convergent, then presurgical icEEG monitoring is unnecessary and
surgical treatment with ECoG (electro-corticography) is performed;
otherwise, presurgical icEEGmonitoring is performed. Another example,
in a presurgical evaluation protocol (Fig. 1B) adopted by seven epilepsy
centers (Haut et al., 2002), if space occupying lesion is found on MRI
and there are no conﬂicting EEG ﬁndings, then surgery (for TLE or
ETLE) will be performed (without presurgical icEEG monitoring);
otherwise, if ﬁndings from MRI, ictal or interictal EEG, PET and/or
SPECT, etc. meet criteria for medial temporal lobe onset, then anterior
temporal lobectomy will be performed (without presurgical icEEG
monitoring); otherwise, invasive presurgical monitoring is required. It
has been reported that non-invasive presurgical evaluation can be
achieved in a safe and cost-effective manner in ~25–50% of patients
with drug-resistant seizures, while ~50–75% presurgical evaluation
remains invasive (Health Net, 2010).
2.7. Summary
Taken together, promising non-invasive neuroimaging such as
MEG/MSI, PET and ictal SPECT alone or in combination so far still cannot
replace invasive icEEG in localizing seizure focus especially in non-
lesional epilepsy or ETLE, but neuroimaging could reduce the need for
invasive presurgical monitoring in certain cases.
3. Can neuroimaging identify subtle lesions such as those in dual
pathology which often causes surgical failure?
3.1. Identifying lesions in dual pathology
Dual pathology refers to the coexistence ofmesial temporal sclerosis
(MTS) and extrahippocampal lesion (Harroud et al., 2012). The lesions
could be temporal or extratemporal, and the most common lesions
are developmental abnormalities such as cortical dysplasia (Harroud
et al., 2012; Vale et al., 2012). In epilepsy with dual pathology, the
contribution of hippocampus to seizure generation corresponds to the
degree of hippocampal pathology, while even mild cortical dysplasia
could be epileptogenic (Fauser and Schulze-Bonhage, 2006). It has
been estimated that around 90% patients with developmental abnor-
malities in the temporal lobe have concurrent atrophy of the mesial
structures (Ho et al., 1998; Schwartz and Spencer, 2001), and dual
pathology has been considered the main cause of surgical failures by
some authors (Schwartz and Spencer, 2001; Spencer and Huh, 2008).
A multi-center study by Li et al. reported that resection of both the
lesion and the mesial temporal structures resulted in seizure-free out-
come in 73% of the patients with dual pathology, while resection of
the lesion or the mesial temporal structures alone resulted in seizure-
free outcome in only 12.5%–20% of the patients (Li et al., 1999). Similar
ﬁndings were obtained in another study by this group (Li et al., 1997).Fig. 1. Flow charts indicating the decision making process in epilepsy presurgical evaluation. A
courtesy of Dr. Shibasaki; reprinted with permission from Shibasaki et al., 2007). The branch a
of EEG/ESI and MEG/MSI in focus localization are convergent, then perform surgery with ECoG
7 epilepsy centers (Haut et al., 2002; courtesy of Dr. Haut; reprinted with permission from Ha
criteria: (1) Interictal EEG: At least 70% of interictal discharges with a single anterior tempora
discharge conﬁned to one temporal lobe at least one third of seizures, with no conﬂicting dat
slowing present ≥50% of the time during wakefulness. (2) PET: medial temporal hypome
(4) Wada test lateralized (percentage of items recalled after each injection differed by N20%
protocol ﬂow chart (Engel et al., 2010; courtesy of Dr. Engel; reprinted with permission from EIdentiﬁcation of the lesion in dual pathology is a challenge because
mild cortical dysplasia can hardly be revealed by current neuroimaging
techniques (Abosch et al., 2002; Hennessy et al., 2000). In addition, early
signs of mesial temporal sclerosis such as mild hippocampal atrophy
can be missed by MRI visual assessment. However, quantitative MRI is
of value in identifying such subtle changes (Li et al., 1999).
Compared with the detection of MTS, identiﬁcation of developmen-
tal lesions in dual pathology is more challenging. 87% of patients with
focal cortical dysplasia (FCD) type I and 33% of those with FCD type II
have unremarkable MRI, which indicated the limited power of conven-
tional MRI to detect subtle dysplastic changes (Krsek et al., 2009).
Quantitative MRI morphometry techniques such as VBM, voxel-based
intensity analysis and sulcal morphometry have demonstrated
increased sensitivity in FCD detection, compared with MRI visual
inspection (Bruggemann et al., 2007; Colliot et al., 2006a). Each of
these analyses has strengths and limitations, and the combination of
such techniques could improve the detection of subtle dysplastic lesions
overlapping with seizure focus undetected by MRI (Bernasconi, 2004;
Bernasconi et al., 2011). Antel et al. developed an automated FCD
detection system that combined multiple computational models of
MRI characteristics and texture analysis, and the system detected 83%
(15/18) of cases including 4 of 7 lesions that had eludedMRI assessment
(Antel et al., 2003; Bernasconi, 2004). The systemwas further improved
in FCD coverage (Colliot et al., 2006b), but it lacked the sensitivity in
detecting subtle dysplastic lesions due to the absence of cortical
topological information. Besson et al. used a surfaced-based texture
approach (which preserves cortical topology) combined with mor-
phometry analysis (which captures sulcal depth and curvature features
of FCD), and identiﬁed 89% (17/19) of small, histologically proven FCDs
undetected on MRI (Besson et al., 2008), while the speciﬁcity of such
methods needed to be improved.
Since the lesions in dual pathology are usually mild and the
abnormalities of lesional tissue are subtle, the detection power of MRI
imaging with the most advanced quantitative techniques sometimes is
not sufﬁcient to detect such subtle changes (Abosch et al., 2002;
Harroud et al., 2012). Focus localization could be very difﬁcult when le-
sions or epileptic abnormalities are so subtle that they appear to be
nonlesional and elude from quantitative MRI and other imaging modali-
ties (PET, SPECT, etc.). In addition, multiple seizure foci may be in an
epileptic network in the temporal or extra-temporal regions, and neuro-
imaging tests may fail to capture or distinguish epileptic discharges of
the dominant seizure focus that initiates most seizures, ending up with
contradictory or non-localizing imaging ﬁndings. In bilateral epilepsy,
the hemisphere with the most abnormality detected by neuroimaging
such as MRS might not be the side of seizure origin (Hammen and
Kuzniecky, 2012). Failing to identify the focus of seizure origin might ei-
ther exclude the surgical candidate from surgery, or result in resection
error or incomplete resection (leaving the dominant seizure focus more
or less intact) which causes poor outcome and surgical failure. Therefore,
invasive icEEG is needed especially in these challenging cases to further
detect epileptic abnormality and improve focus localization.
3.2. Summary
Taken together, a multimodality approach including neuroimaging
and icEEG is needed to identify subtle lesions in presurgical evaluation
which may enhance surgical outcome and reduce surgical failure.. Decision tree for source localization in Kyoto University Hospital (Shibasaki et al., 2007;
fter MEG analysis was in parallel with the main stream of evaluation (i.e., if the ﬁndings
; otherwise, perform invasive monitoring). B. Decision tree for invasive monitoring across
ut et al., 2002). Major and minor criteria supporting medial temporal lobe onset: 1. Major
l ﬁeld, in a sample of ≥50 discharges. (2) Ictal EEG: Seizure with rhythmic theta or alpha
a. (3) MRI: Mesial temporal sclerosis. 2. Minor criteria: (1) Interictal focal temporal EEG
tabolism (required if major criteria are 1 and 2). (3) SPECT: temporal hypoperfusion.
). (5)Neuropsychological testing: medial temporal deﬁcits present. C. Multicenter ERSET
ngel et al., 2010).
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eloquent cortex?
4.1. Localizing vital eloquent cortex with neuroimaging
In order to protect neurological functions, mapping the motor,
sensory and language areas and assessing the language-dominant
hemisphere are the main tasks of localizing vital eloquent cortex in
presurgical planning. Traditionally, these tasks are performed by inva-
sive tests such as presurgical Wada test and intraoperative ECoG
(Rutten and Ramsey, 2010). Intraoperative ECoG could identify motor,
sensory and language areas, but it has limited ﬁeld of view, requires
an awake patient (via local anesthesia), and sometimes can only be
performed in adolescents (Tripathi et al., 2010). Functional MRI (fMRI)
is helpful in mapping motor, sensory and memory functions, and
assessing the language-dominant hemisphere (Binder et al., 2002;
Bizzi et al., 2008; Roessler et al., 2005; Rutten et al., 2010). Lateralization
of the language function with fMRI is reliable and fMRI studies of lan-
guage lateralization have demonstrated an 80–90% concordance with
Wada test (Binder et al., 2002; Bizzi et al., 2008; Detre et al., 1998;
Golby et al., 2002; Lehéricy et al., 2000; Pouratian et al., 2002; Rutten
et al., 2002; Sabsevitz et al., 2003; Yetkin et al., 1998). It has been
found that language lateralization with fMRI is as reliable as with
Wada test and maybe more reliable than speech arrest following ECoG
(Carpentier et al., 2001; Fernández et al., 2003), which supports that
fMRI could be a non-invasive alternative toWada test in language later-
alization (Binder, 2011a). Further, presurgical fMRI is useful for
predicting verbal memory decline after left anterior temporal lobecto-
my (Binder et al., 2008) and selective reminding test (i.e., word list
learning and delayed recall) is often used as the memory measure
(Binder et al., 2008; Binder, 2011; Binder et al., 2011). However, mem-
ory lateralization with fMRI is not clinically validated and fMRI is less
promising in localizing language area (Rutten and Ramsey, 2010;
Seeck et al., 2010), the accuracy is relatively low (sensitivity: 80%, spec-
iﬁcity: 78%) (Bizzi et al., 2008), and a validated fMRI protocol is needed
tomap language area (Binder, 2011b). For details onmapping language
area with fMRI, see reviews by Rutten and Ramsey (2010), and Binder
(2011a).
When a patient has difﬁculty to undergo fMRI, MEG/MSI (or EEG/ESI)
could be an alternative to mapping functional cortex in surgical planning
(Bast et al., 2007; Seeck et al., 2010). High resolution MEG/MSI has been
used to localize sensory and motor cortex. Studies have shown that
MEG/MSI results in sensory and motor evoked ﬁelds are well correlated
with those of ECoG (Ganslandt et al., 1999; Rezai et al., 1996). In addi-
tion, the use of MEG/MSI or EEG/ESI in language localization might be
promising (Doss et al., 2009; Hirata et al., 2010; McDonald et al.,
2009; Seeck et al., 2010). Further, EEG/ESI has been applied to localizing
the somatosensory cortex and the results are comparable to those of
MEG/MSI (Bast et al., 2007).4.2. Summary
Taken together, although non-invasive neuroimaging such as fMRI,
MEG/MSI and EEG/ESI still cannot replace invasive tests, they have
reduced the need for ECoG in mapping the eloquent cortex, and fMRI
might replace invasive Wada test in language lateralization.Fig. 2.Multimodal neuroimaging (MRI, DTI, MEG, etc.) in source localization. A. Presurgical 1H
hippocampus (with decreased NAA in 1HMRS) and the seizure focus is in the left anterior temp
temporal lobes of both hemispheres with lower hypometabolism in the right temporal regio
C. (De Tiègea et al., 2008; courtesy of Dr Xavier De Tiège; reprinted with permission from De
shownon the co-registered 3D-T1MRI. D. Fiber tracking fromDTI scan: Corticospinal tract (CST)
E. Presurgical EEG–fMRI of a patient with bilateral TLE and ETLE, and EEG–fMRI identiﬁed seizu5. How to assess the utility of presurgical neuroimaging
more accurately?
One drawback of the neuroimaging validation studies (using invasive
tests or the surgical site as reference standard) conducted by individual
groups (or epilepsy centers) is the large variability across studies/
centers. The varied accuracy (measured by sensitivity and speciﬁcity)
of neuroimaging tests across studies may be due to a number of factors
such as the different subject samples, the criteria and protocols of
presurgical evaluation among centers, the imaging equipment and
parameters used at each center, and pathological substrates of patients
in these studies. Differences in pathological substrates such as mesial
temporal sclerosis (MTS), developmental lesion and tumor may result
in the wide range of sensitivity and speciﬁcity of neuroimaging modali-
ties (Spencer et al., 1995). For example, PET and MRI are more sensitive
to MTS than SPECT (100%, 95% vs. 70%), while PET, MRI and SPECT are
equally sensitive to developmental lesions (88–92%), and MRI is most
sensitive (96%) and SPECT least (82%) to tumors (Spencer et al., 1995).
Further, the protocols of presurgical evaluation and criteria for focus
localization using intracranial monitoring differ among centers, which
may result in varied presurgicalﬁndings, surgical decisions andoutcomes.
The true utility of presurgical neuroimaging often eludes from stud-
ies at individual centers due to such high variability. Thus, multicenter
studies using consistent protocols and criteria for surgical planning
have the advantage to reduce the variation across centers and reveal
the true utility of neuroimaging in presurgical evaluation.
5.1. A review of multicenter studies
Pioneering work of multicenter research in this area ﬁrst appeared
one and a half decades ago. Silander et al. studied 152 patients in 3
epilepsy centers across Sweden, and found that non-invasive tools
such as EEG, CT/MRI, and PET/SPECT localized the seizure focus in 85%
of the young patients and 95% of the adult patients in presurgical
evaluation (Silander et al., 1997).
In the early 2000s, Haut et al. conducted a 7-center study on the
interrater reliability of presurgical testing and surgical decisions, and
found that agreement was excellent for extracranial EEG lateralization
(intraclass correlation coefﬁcient: 0.80), MRI lateralization (0.95) and
localization (0.91), Wada lateralization (0.95), icEEG localization
(0.79), decision on whether to perform surgery (0.83); but the agree-
ment on the decision to perform intracranial monitoring was poor
(0.54) (Haut et al., 2002). In the samemulticenter study, Berg et al. stud-
ied the localizing evidence of seizure focus and found that among the
565 surgical candidates, 34% underwent intracranial monitoring and
85% had surgery, while up to 30% of patients did not have surgery due
to lack of clear localizing evidence (Berg et al., 2003). Spencer et al.
(2003) further reported that among the 355 patients who underwent
surgery, medial temporal resection signiﬁcantly reduced seizures (77%
1-year remission) compared with neocortical resection (56% 1-year
remission). These results have revealed a rough picture on the variability
in the interpretation of neuroimaging in presurgical evaluation across
centers and demonstrated the consensus on neuroimaging tests, surgical
decisions, and overall outcomes across these centers.
In recent years, Zaknun et al. (2008) investigated 74 patients with
TLE in a four-center study, and reported that the localization sensitivity
for MRI was 86%, ictal SPECT 84% and ictal EEG/ESI 70%, and the seizureMR spectroscopy and MRI of a patient with TLE, who has hippocampal sclerosis in the left
oral region. B. FDG-PET scan of a patient with bilateral TLE. Hypometabolism is seen in the
n. Other neuroimaging tests are needed to further localize the dominant seizure focus.
Tiègea et al., 2008) Right posterior temporal sources detected by MEG found in a patient
tracking to assess diffusion abnormalities in a patient before functional hemispherectomy.
re foci in both hemispheres with major right frontal and temporal sources.
42 J. Zhang et al. / NeuroImage: Clinical 4 (2014) 35–44free outcome was 89%. They concluded that compared with MRI and
EEG/ESI, ictal SPECT is an effective diagnostic modality for identifying
seizure origin in TLE (Zaknun et al., 2008). In a more recent multicenter
study, Matsuda et al. (2009) compared SISCOMwith regular ictal SPECT
and found that SISCOM provides higher predictive value of good surgi-
cal outcome and more reliability on the diagnosis of the epileptogenic
focus than side-by-side comparison in medically intractable partial
epilepsy. Further, multicenter clinical trials such as Early Randomized
Surgical Epilepsy Trial (ERSET) (Engel et al., 2010) with rigorous
presurgical protocols and criteria might be the best organized and
most effective multicenter studies.
In addition to source localization, efforts have beenmade to localize
the vital eloquent cortex in surgical planning across centers and proved
the value of non-invasive imaging techniques as well as new protocols.
For example, to map language cortex, Binder et al. (2011b) applied an
fMRI (Story–Math task) protocol to seven centers, and found that the
protocol provides a reliable method for activation of surgical regions
of interest in the anterior TLE.
Taken together, multicenter studies have reduced the variability
across epilepsy centers and revealed a more close-to-truth utility of
neuroimaging in surgical planning.
5.2. The call for randomized controlled trials
Most comparative validation studies and multicenter studies
assessing the diagnostic accuracy of presurgical neuroimaging tests
are retrospective studies. Such retrospective studies have limitations
in study design (e.g., limited statistical power to draw strong conclu-
sions) and cannot provide much useful clinical information (Burch
et al., 2012; Whiting et al., 2006). To assess the clinical utility of neuro-
imaging more accurately, it would be useful to randomize patients to
groups using neuroimaging techniques and to other groups using inva-
sive techniques. Whiting et al. (2006) realized such need and called for
randomized controlled trials (RCTs). RCTswere regarded as themost re-
liable method to investigate the utility of neuroimaging in the workup
for epilepsy surgery and it could examine single tests or combinations
of tests on patient outcome. The efﬁcacy of surgical treatment for
drug-resistant TLE was demonstrated convincingly by a RCT in 2001
where 80 patients were randomly assigned to surgery (n = 40) and
therapy of anti-epilepsy drugs (AED) (n = 40) and at one year, patients
in the surgical group had signiﬁcantly higher percentage (58% vs. 8%) of
seizure-free outcome, fewer cognitive impairments and better quality of
life than those in the AED group (Wiebe et al., 2001). Accordingly,
Chernov et al. (2009) pointed out that carefully designed multi-center
prospective trials can clarify the usefulness of neuroimaging in seizure
investigation. Further, Okonma et al. (2011) proposed that multicenter
RCTs are needed to incorporate technical advances for identifying the
seizure focus and tissue at risk to identify the extent of epilepsy resection.
One key difference causing the variation of epilepsy surgical
outcome across various epilepsy centers lies in the clinical decision-
making process. The decision process of determining whether to
perform invasive intracranial EEG monitoring varies among centers
(Fig. 1A (Shibasaki et al., 2007) vs. Fig. 1B (Haut et al., 2002)), which in-
evitably affects the surgical outcome. Engel et al. (2010) have outlined
the design considerations for ERSET, a multicenter RCT of early surgical
intervention (Fig. 1C): the patients with TLE are randomized by center,
age (12–16 or ≥17) and the side of ictal onset, and the randomization
includes blocking within each stratum. The rigorous trial designs to
assess surgical interventions in epilepsy provide evidence to guide
treatment across 16 centers in the ERSET. To determine whether early
surgical intervention could better control seizures, Engel et al. (2012)
randomized 38 patients (who had seizures for no more than 2 years
following trials of 2 AEDs) to medical (AED) group (n = 23) and
surgical (anteromesial temporal resection) plus AED group (n = 15),
and found that surgery plus AED treatment resulted in a higher percent-
age of seizure-free outcome (73.3% vs. 0%) and improved quality of lifeduring the 2nd year follow-up than continuedAED treatment alone. The
preliminary results of the multicenter trial ERSET indicate that early
surgical intervention is more effective in seizure control than continued
AED treatment. Similar multicenter RCTs could be performed to reveal
the efﬁcacy and relative effectiveness of presurgical neuroimaging and
icEEG.
5.3. Summary
Taken together, the clinical utility of neuroimaging could be assessed
more accurately by multicenter studies and RCTs, which could
standardize the decision-making process in presurgical evaluation and
reveal the efﬁcacy of neuroimaging and icEEG.
6. Conclusions
In summary, over the years, the advances of non-invasive neuroim-
aging techniques have provided promising tools for epilepsy surgical
planning. Presurgical neuroimaging techniques such as MRI morphom-
etry, DTI, fMRI, EEG/ESI, ictal SPECT/SISCOM andMEG/MSI havemade it
possible to capture previously undetected dysplastic lesions and other
epileptic abnormalities, improve the localization of the epileptogenic
zone and the eloquent cortex, and reduce the need for icEEG, but they
still cannot replace icEEG in surgical planning. Thus, a multimodality
approach including neuroimaging and invasive icEEG is needed
(e.g., to identify subtle abnormalities) in presurgical evaluation espe-
cially in non-lesional and extratemporal lobe epilepsies. In addition, in
localization or lateralization of vital eloquent cortex, fMRI may be a
non-invasive alternative to Wada test in language lateralization.
Further, due to large variability across epilepsy centers and study design
problems, multicenter studies and RCTs are needed to reveal the true
value of presurgical neuroimaging.With technical advances (e.g., higher
resolution), neuroimaging may play a greater role in presurgical evalu-
ation, reduce the costs and risks of epilepsy surgery and provide surgical
options for more patients with drug-resistant epilepsy.
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